IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice

Qingyu Huang,Tongqing Chen,Jian Li,Yiming Wang,Huairui Shi,Yifei Yu,Qingwei Ji,Xiaoyan Shen,Tao Sun,Haiming Shi,Xinping Luo,Bo Jin,Yan You,Bangwei Wu

DOI: https://doi.org/10.1186/s12967-024-05250-3

IF: 8.44

2024-05-26

Journal of Translational Medicine

Abstract:Diabetic cardiomyopathy (DCM), a serious complication of diabetes, leads to structural and functional abnormalities of the heart and ultimately evolves to heart failure. IL-37 exerts a substantial influence on the regulation of inflammation and metabolism. Whether IL-37 is involved in DCM is unknown.

medicine, research & experimental

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to explore the role of IL - 37 in diabetic cardiomyopathy (DCM) and its underlying mechanisms. Specifically, the main research questions include:

1. **Expression and role of IL - 37 in DCM**:
- Researchers first observed an increase in IL - 37 levels in the plasma of DCM patients and speculated that it might be related to the deterioration of cardiac function.
- Is IL - 37 involved in the occurrence and development of DCM? If so, how does it play a role?

2. **Effect of IL - 37 on cardiac function and fibrosis**:
- In in - vivo experiments, researchers injected recombinant IL - 37 or induced IL - 37 expression in high - fat - diet - induced diabetic mice to evaluate its effects on cardiac function, myocardial fibrosis, and cardiomyocyte apoptosis.
- Can IL - 37 improve cardiac function and structural abnormalities in DCM mice?

3. **Protective effect of IL - 37 on mitochondrial function**:
- Researchers further explored the protective effect of IL - 37 on mitochondrial function. They found that hyperglycemia damages mitochondria through the SIRT1/AMPK/PGC1α signaling pathway, leading to cardiomyocyte apoptosis and the release of extracellular vesicles containing mtDNA.
- Can IL - 37 reduce mitochondrial damage by maintaining the activity of the SIRT1/AMPK/PGC1α axis, reduce the release of mtDNA - enriched vesicles, and thus slow down the progress of DCM?

4. **Effect of IL - 37 on the interaction between cardiomyocytes and fibroblasts**:
- Researchers also studied the effect of IL - 37 on the interaction between cardiomyocytes and fibroblasts. They found that mtDNA - enriched vesicles released by cardiomyocytes are phagocytosed by fibroblasts, activating the TLR9 signal and cGAS - STING pathway, and initiating the fibrosis process and adverse remodeling.
- Can IL - 37 reduce the fibrotic activation of fibroblasts by regulating the release of mtDNA - enriched vesicles by cardiomyocytes?

In summary, this paper attempts to reveal the protective role of IL - 37 in DCM and its molecular mechanisms, providing new ideas and potential targets for the treatment of DCM.